Cerebral microbleeds, CSF p-tau, and cognitive decline: Significance of anatomic distribution

American Journal of Neuroradiology

Volumn 36, Issue 9, 2015, Pages 1635-1641

  Chiang, G C ^a   Cruz Hernandez, J C ^b   Kantarci, K ^c   Jack, C R ^c   Weiner, M W ^d  

^a NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^b School of Operations Research and Industrial Engineering   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BIOLOGICAL MARKER; PHOSPHOPROTEIN; PHOSPHORYLATED TAU 181 PROTEIN; TAU PROTEIN; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; AMYLOIDOSIS; ARTICLE; BRAIN AMYLOIDOSIS; BRAIN DISEASE; BRAIN HEMORRHAGE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; IMAGE ANALYSIS; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; NEUROANATOMY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; PATHOLOGICAL ANATOMY; PROTEIN CEREBROSPINAL FLUID LEVEL; TAUOPATHY; CEREBRAL HEMORRHAGE; MIDDLE AGED; PATHOLOGY;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; CEREBRAL HEMORRHAGE; COGNITIVE DYSFUNCTION; FEMALE; HUMANS; MALE; MIDDLE AGED; TAU PROTEINS;

EID: 84941340620     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A4351     Document Type: Article

References (40)

1. Poels MM, Vernooij MW, Ikram MA, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam Scan Study. Stroke 2010;41:S103-06
2. Cordonnier C, Al-Shahi Salman R, Wardlaw J. Spontaneous brain microbleeds: systematic review, subgroup analyses and standards for study design and reporting. Brain 2007;130:1988-2003
3. Goos JD, Kester MI, Barkhof F, et al. Patients with Alzheimer disease with multiple microbleeds: relation with cerebrospinal fluid biomarkers and cognition. Stroke 2009;40:3455-60
4. Wardlaw JM, Lewis SC, Keir SL, et al. Cerebral microbleeds are associated with lacunar stroke defined clinically and radiologically, independently of white matter lesions. Stroke 2006;37:2633-36
5. Yates PA, Villemagne VL, Ellis KA, et al. Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol 2014;4:205
6. Kantarci K, Gunter JL, Tosakulwong N, et al; Alzheimer's Disease Neuroimaging Initiative. Focal hemosiderin deposits and -amyloid load in the ADNI cohort. Alzheimers Dement 2013;9:S116-23
7. Park JH, Seo SW, Kim C, et al. Pathogenesis of cerebral microbleeds: in vivo imaging of amyloid and subcortical ischemic small vessel disease in 226 individuals with cognitive impairment. Ann Neurol 2013;73:584-93
8. Fazekas F, Kleinert R, Roob G, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2-weightedMRimages in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds. AJNR Am J Neuroradiol 1999;20: 637-42 Medline
9. Schrag M, McAuley G, Pomakian J, et al. Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study. Acta Neuropathol 2010;119:291-302
10. Jack CR Jr, Knopman DS, Jagust WJ, et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013;12:207-16
11. Petersen RC, Aisen PS, Beckett LA, et al. Alzheimer's Disease Neuroimaging Initiative (ADNI): clinical characterization. Neurology 2010;74:201-09
12. Mueller SG, Weiner MW, Thal LJ, et al. Ways toward an early diagnosis in Alzheimer's disease: the Alzheimer's Disease Neuroimaging Initiative (ADNI). Alzheimers Dement 2005;1:55-66
13. Rosen WG, Terry RD, Fuld PA, et al. Pathological verification of ischemic score in differentiation of dementias. Ann Neurol 1980;7: 486-88
14. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. Am J Psychiatry 1984;141:1356-64
15. Gunter JL, Bernstein MA, Borowski BJ, et al. Measurement of MRI scanner performance with the ADNI phantom. Med Phys 2009;36: 2193-205
16. Shaw LM. PENN biomarker core of the Alzheimer's Disease Neuroimaging Initiative. Neurosignals 2008;16:19-23
17. Hansson O, Zetterberg H, Buchhave P, et al. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006; 5:228-34
18. Mitchell A, Brindle N. CSF phosphorylated tau-does it constitute an accurate biological test for Alzheimer's disease? Int J Geriatr Psychiatry 2003;18:407-11
19. Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Ann Neurol 2009;65:403-13
20. Yates PA, Sirisriro R, Villemagne VL, et al; AIBL Research Group. Cerebral microhemorrhage and brain--amyloid in aging and Alzheimer disease. Neurology 2011;77:48-54
21. Kester MI, Goos JD, Teunissen CE, et al. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. JAMA Neurol 2014;71: 855-62
22. Kalaria RN, Ballard C. Overlap between pathology of Alzheimer disease and vascular dementia. Alzheimer Dis Assoc Disord 1999;13: S115-23
23. Vernooij MW, van der Lugt A, Ikram MA. Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study. Neurology 2008;70:1208-14
24. Williams S, Chalmers K, Wilcock GK, et al. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathol Appl Neurobiol 2005;31:414-21
25. Rosidi NL, Zhou J, Pattanaik S, et al. Cortical microhemorrhages cause local inflammation but do not trigger widespread dendrite degeneration. PLoS One 2011;6:e26612
26. Takashima Y, Mori T, Hashimoto M, et al. Clinical correlating factors and cognitive function in community-dwelling healthy subjects with cerebral microbleeds. J Stroke Cerebrovasc 2011;20:105-10
27. Kirsch W, McAuley G, Holshouser B, et al. Serial susceptibility weighted MRI measures brain iron and microbleeds in dementia. J Alzheimers Dis 2009;17:599-609
28. PoelsMM,Ikram MA, van der Lugt A, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology 2012;78:326-33
29. Qiu C, Cotch MF, Sigurdsson S, et al. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology 2010;75: 2221-28
30. Werring DJ, Frazer DW, Coward LJ, et al. Cognitive dysfunction in patients with cerebral microbleeds on T2-weighted gradient-echo MRI. Brain 2004;127:2265-75
31. Patel B, Lawrence AJ, Chung AW, et al. Cerebral microbleeds and cognition in patients with symptomatic small vessel disease. Stroke 2013;44:356-61
32. Gregoire SM, Scheffler G, Jäger HR, et al. Strictly lobar microbleeds are associated with executive impairment in patients with ischemic stroke or transient ischemic attack. Stroke 2013;44: 1267-72
33. Tang WK, Chen YK, Lu JY, et al. Absence of cerebral microbleeds predicts reversion of vascular "cognitive impairment no dementia" in stroke. Int J Stroke 2011;6:498-505
34. Pettersen JA, Sathiyamoorthy G, Gao FQ, et al. Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol 2008;65:790-95
35. Nakata Y, Shiga K, Yoshikawa K, et al. Subclinical brain hemorrhages in Alzheimer's disease: evaluation by magnetic resonance T2-weighted images. Ann N Y Acad Sci 2002;977:169-72
36. van der Vlies AE, Goos JD, Barkhof F, et al. Microbleeds do not affect rate of cognitive decline in Alzheimer disease. Neurology 2012;79: 763-69
37. Haller S, Bartsch A, Nguyen D, et al. Cerebral microhemorrhage and iron deposition in mild cognitive impairment: susceptibilityweighted MR imaging assessment. Radiology 2010;257:764-73
38. Ayaz M, Boikov AS, Haacke EM, et al. Imaging cerebral microbleeds using susceptibility weighted imaging: one step toward detecting vascular dementia. J Magn Reson Imaging 2010;31:142-48
39. Miwa K, Tanaka M, Okazaki S, et al. Multiple or mixed cerebral microbleeds and dementia in patients with vascular risk factors. Neurology 2014;83:646-53
40. Arvanitakis Z, Leurgans SE, Wang Z, et al. Cerebral amyloid angiopathy pathology and cognitive domains in older persons. Ann Neurol 2011;69:320-27